Management of clinical Stage I nonseminomatous germ-cell testis tumors

References

• Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl. J Med. 337,242–253 (1997).
   PubMed Web of Science ®Google Scholar
• ••Comprehensive review of all aspects ofgerm-cell tumors.
   Google Scholar
• Einhorn LH. Treatment of testicular cancer: a new and improved model." Clin. Oncol. 8,1777-1781 (1990).
   Google Scholar
• •Summary, even if somewhat old, of the experience of one of the investigator who has defined the standards of germ-cell tumor treatment.
   Google Scholar
• Ulbright TM. Germ cell neoplasms of the testis. Am. J. Path.17, 1075–1091 (1993).
   Web of Science ®Google Scholar
• International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin. Oncol. 15, 594–603 (1997).
   PubMed Web of Science ®Google Scholar
• Culine S, Kramar A, Biron P, Droz JP. Chemotherapy in adult germ-cell tumors. Crit. Rev Oncol Hematol. 22,229–263 (1996).
   PubMed Web of Science ®Google Scholar
• Droz JP, Culine S. New prospects for the treatment of germ-cell tumours. Exp. Opin. Invest. Drugs7, 1139–1157 (1998).
   PubMedGoogle Scholar
• Peckham MJ, Barrett A, Husband JE, Hendry WE Orchidectomy alone in testicular Stage I nonseminomatous germ-cell tumours. Lancet 2,678–680 (1982).
   PubMedGoogle Scholar
• Cullen MH, Stenning SP, Parkinson MC et al. Short-course adjuvant chemotherapy in high-risk Stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report. J. Clin. Oncol. 14,1106–1113 (1996).
   PubMed Web of Science ®Google Scholar
• •Largest study of adjuvant chemotherapy in high-risk clinical Stage I nonseminomatous germ-cell tumor patients.
   Google Scholar
• Donohue JP, Foster RS, Rowland RG, Bihrle R, Jones J, Geier G. Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol. 144, 287–291 (1990).
   PubMed Web of Science ®Google Scholar
• Leisinger HJ, Donohue JP. The role of retroperitoneal surgery in testis cancer. Grit. Rev Oncol. Hematol 44,71–80 (2002).
   PubMedGoogle Scholar
• Droz JP, van Oosterom AT Treatment options in clinical Stage I nonseminomatous germ cell tumours of the testis: a wager on the future? A review. Eur. Cancer 29A, 1038–1044 (1993).
   PubMed Web of Science ®Google Scholar
• Madej G, Pawinski A. Risk-related adjuvant chemotherapy for Stage I nonseminoma of the testis. Gin. Oncol. 3, 270–272 (1991).
   Google Scholar
• Oliver Rf, Raja MA, Ong J, Gallagher CJ. Pilot study to evaluate impact of a policy of adjuvant chemotherapy for high risk Stage I malignant teratoma on overall relapse rate of Stage I cancer patients. Urol 148, 1453–1455 (1992).
   Google Scholar
• Pont J, Albrecht W, Postner G, Sellner F, Angel K, How W Adjuvant chemotherapy for high-risk clinical Stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial. J. Clin. Oncol. 14, 441–448 (1996).
   PubMed Web of Science ®Google Scholar
• Chevreau C, Soulié M, Rischmann P et al. Adjuvant chemotherapy in high risk Stage I nonseminomatous germ cell tumors. Proc. Am. Soc. Clin. Oncol. 16 (1997) (Abstract) .
   Google Scholar
• Klepp O, Dahl O, Flodgren P et al. Risk- adapted treatment of clinical Stage 1 non-seminoma testis cancer. Eur. J Cancer 33, 1038–1044 (1997).
   Google Scholar
• Bohlen D, Burkhard FC, Mills R, Sonntag RVV, Studer UE. Fertility and sexual function following orchiectomy and two cycles of chemotherapy for Stage I high-risk nonseminomatous germ cell cancer. J. Urol 165,441–444 (2001).
   Google Scholar
• Javadpour N, Canning DA, O'Connell KJ, Young JD. Predictors of recurrent clinical Stage I nonseminomatous testicular cancer. A prospective clinicopathologic study. Urology27, 508–511 (1986).
   Google Scholar
• Fung CY, Kalish LA, Brodsky GL, Richie JP, Garnick MB. Stage I nonseminomatous germ cell testicular tumor: prediction of metastatic potential by primary histopathology. j Gun. Oncol 6,1467–1473 (1988).
   Google Scholar
• Klepp O, Olsson AM, Henrikson H et al. Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group. J Clin. Oncol 8, 509–518 (1990).
   PubMed Web of Science ®Google Scholar
• McLeod DG, Weiss RB, Stablein DM et al. Staging relationships and outcome in early Stage testicular cancer: a report from the Testicular Cancer Intergroup Study. J Urol. 145,1178–1183 (1991).
   PubMedGoogle Scholar
• Sesterhenn IA, Weiss RB, Mostofi FK et al. Prognosis and other clinical correlates of pathologic review in Stage land II testicular carcinoma: a report from the Testicular Cancer Intergroup Study. J Clin. Oncol. 10,69–78 (1992).
   PubMed Web of Science ®Google Scholar
• Chraibi Y, Culine S, Terrier-Lacombe MJ, Kramar A, Kaftan J, Droz JP. [Prognostic factors for extratesticular involvement in Stage I testicular cancer. A series of 58 cases]. Bull. Cancer 81,311–317 (1994).
   Google Scholar
• Heidenreich A, Sesterhenn IA, Mostofi FK, Moil JW. Prognostic risk factors that identify patients with clinical Stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer83, 1002–1011 (1998).
   PubMed Web of Science ®Google Scholar
• Hermans BP, Sweeney CJ, Foster RS, Einhorn LE, Donohue JP. Risk of systemic metastases in clinical Stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection. J Urol. 163,1721–1724 (2000).
   Google Scholar
• Sogani PC, Whitmore WF Jr, Herr HW et al Orchiectomy alone in the treatment of clinical Stage I nonseminomatous germ cell tumor of the testis. J. Clin. Oncol. 2(4), 267–270 (1984).
   Google Scholar
• Hoskin P, Dilly S, Easton D, Horwich A, Hendry W Peckham MJ. Prognostic factors in Stage I nonseminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy. J. Clin. Oncol 4(7), 1031–1036 (1986).
   Google Scholar
• Pizzocaro G, Zanoni F, Salvioni R, Milani A, Piva L, Pliotti S. Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical Stage I nonseminomatous germ cell tumors of the testis. J. Urol. 138(6), 1393–1396 (1987).
   PubMedGoogle Scholar
• Freedman LS, Parkinson MC, Jones WG et al Histopathology in the prediction of relapse of patients with Stage I testicular teratoma treated by orchidectomy alone. Lancet2(8554), 294–298 (1987). Best published study of prognostic factors of extra-testicular involvement in clinical Stage I nonseminomatous germ-cell tumor patients. See also report on the validation of the model [36].
   Google Scholar
• Dunphy CH, Ayala AG, Swanson D, Logothetis C. A clinicopathologic study of 93 patients on a surveillance protocol after orchiectomy alone. Cancer 62,1202–1206 (1988).
   PubMed Web of Science ®Google Scholar
• Thompson PI, Nixon J, Harvey VJ. Disease relapse in patients with Stage I nonseminomatous germ cell tumor of thetestis on active surveillance. J. Clin. Oncol. 6(10), 1597–1603 (1988).
   Google Scholar
• Sturgeon JF, Jewett MA, Alison RE et al. Surveillance after orchidectomy for patients with clinical Stage I nonseminomatous testistumors.j Clin. Oncol. 10(4)564-568 (1992).
   Google Scholar
• Thomas R, Dearnaley D, Nicholls J, Norman A, Sampson S, Horwich A. An analysis of surveillance for Stage I combined teratoma-seminoma of the testis. Bcj Cancer74(1), 59–62 (1996).
   Google Scholar
• Coils BM, Harvey VJ, Skelton L et al Results of the surveillance policy of Stage I nonseminomatous germ cell testicular tumours. Br. Urol. 70(4), 423–428 (1992).
   PubMedGoogle Scholar
• Alexandre J, Fizazi K, Mahe C et al. Stage I nonseminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low-risk of relapse. Eur. J. Cancer 37(5), 576–582 (2001).
   Google Scholar
• Read G, Stenning SP, Cullen MET et al. Medical Research Council prospective study of surveillance for Stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J. Clin. Oncol. 10(11), 1762–1768 (1992).
   Google Scholar
• Albers P, Siener R, Hartmann M et al. Risk factors for relapse in Stage I nonseminomatous germ-cell tumors: preliminary results of the german multicenter trial. German testicular cancer study group. Lit. j Cancer83,828–830 (1999).
   Google Scholar
• Moul JW, McCarthy WF, Fernandez EB, Sesterhenn IA. Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical Stage I nonseminomatous testicular cancer. Cancer Res. 54(2), 362–364 (1994).
   Google Scholar
• Albers P, Bender H, Yilmaz H, Schoeneich G, Biersack HJ, Mueller SC. Positron emission tomography in the clinical staging of patients with Stage I and II testicular germ cell tumors. Urology53,808–811 (1999).
   PubMed Web of Science ®Google Scholar
• Lassen U, Daugaard G, Rorth M, Eigtved A, Hojgaard L. Positron emission tomography with 18F-fluoro-deoxyglucose in clinical Stage I nonseminomatous germ cell tumors. Proc. Am. Soc. Clin. Oncol. 19, 340a (2000) (Abstract 1336).
   Google Scholar
• Kaldor JM, Day NE, Band P et al. Second malignancies following testicular cancer,ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int. I Cancer39, 571–585 (1987).
   PubMed Web of Science ®Google Scholar
• Kollmannsberger C, Beyer J, Droz JP et al. Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors. J. Clin. Oncol. 16(10), 3386–3391 (1998).
   Google Scholar
• Baniel J, Roth BJ, Foster RS, Donohue JP. Cost- and risk-benefit considerations in the management of clinical stage I nonseminomatous testicular tumors. Ann. Surg. Oncol. 3(1), 86–93 (1996).
   Google Scholar
• Carrere MO, Moumjid-Ferdjaoui N, Charavel M, Bremond A. Eliciting patients' preferences for adjuvant chemotherapy in breast cancer: development and validation of a bedside decision-making instrument in a French Regional Cancer Centre. Health Expect. 3(2), 97–113 (2000).
   Google Scholar
• Moul JW, Heidenreich A. Prognostic factors in low-stage nonseminomatous testicular cancer. Oncology10,1359–1368 (1996).
   PubMedGoogle Scholar
• Cullen MET, Billingham LJ, Cook J, Woodroff CM. Management preferences in Stage I nonseminomatous germ-cell tumours of the testis: an investigation among patients, controls and oncologists. Br. Cancer74, 1487–1491 (1996).
   Google Scholar